SCHEMBL2426313

SCHEMBL2426313

O=c1oc2ccccc2cc1C1=Nc2ccccc2C1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.51
RAB9A P51151 8/20 0.51
KDM4E B2RXH2 7/20 0.51
MAOB P27338 3/20 0.51
LMNA P02545 3/20 0.49
NPC1 O15118 7/20 0.49
HPGD P15428 6/20 0.49
SMN1; SMN2 Q16637 6/20 0.49
MAPT P10636 5/20 0.49
GAA P10253 3/20 0.49
GLA P06280 3/20 0.49
TP53 P04637 3/20 0.49
HSD17B10 Q99714 3/20 0.49
CASP1 P29466 2/20 0.49
CASP7 P55210 2/20 0.49
PKM P14618 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
GAPDH P04406 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13959678 0.80 CYP19A1 (0.50) ALDH1A1RAB9AKDM4EMAOBLMNA
SCHEMBL1021869 0.80 DPP4 (0.46) ALDH1A1RAB9AKDM4EMAOBLMNA
SCHEMBL29517170 0.75 RAB9A (0.78) ALDH1A1RAB9AKDM4EMAOBLMNA
SCHEMBL13522914 0.73 MAPT (0.45) ALDH1A1KDM4ELMNAHPGDSMN1; SMN2
SCHEMBL2426603 0.72 RAB9A (0.55) ALDH1A1RAB9AKDM4EMAOBLMNA
SCHEMBL13961627 0.71 HRH4 (0.46) ALDH1A1RAB9AKDM4ELMNANPC1
SCHEMBL5021700 0.69 NOS3 (0.46) ALDH1A1RAB9AKDM4ELMNANPC1
SCHEMBL177366 0.69 RAB9A (1.00) ALDH1A1RAB9AKDM4EMAOBLMNA
SCHEMBL30356319 0.69 RAB9A (1.00) ALDH1A1RAB9AKDM4EMAOBLMNA
SCHEMBL30417366 0.69 RAB9A (0.68) ALDH1A1RAB9AKDM4EMAOBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2364318-A1 CYCLOMETALATED TRANSITION METAL COMPLEXES FOR MULTIPLEX ANALYTE DETECTION Bio-Rad Laboratories, Inc. (US) 2011-09-14 EP claimed
WO-2010065514-A1 CYCLOMETALATED TRANSITION METAL COMPLEXES FOR MULTIPLEX ANALYTE DETECTION BIO-RAD LABORATORIES, INC. (US) 2010-06-10 WO claimed
US-20100144046-A1 CYCLOMETALATED TRANSITION METAL COMPLEXES FOR MULTIPLEX ANALYTE DETECTION BIO-RAD LABORATORIES, INC. (US) 2010-06-10 US claimed
US-8664396-B2 Photoluminescent metal complexes for protein staining BIO-RAD LABORATORIES, INC. (US) 2014-03-04 US disclosed
US-20100144046-A1 CYCLOMETALATED TRANSITION METAL COMPLEXES FOR MULTIPLEX ANALYTE DETECTION BIO-RAD LABORATORIES, INC. (US) 2010-06-10 US disclosed
US-20090131640-A1 PHOTOLUMINESCENT METAL COMPLEXES FOR PROTEIN STAINING BIO-RAD LABORATORIES, INC. (US) 2009-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131640-A1 PHOTOLUMINESCENT METAL COMPLEXES FOR PROTEIN STAINING NR2E3, NR2C2, ORC3 ALDH1A1 3522/4885RAB9A 4244/4885KDM4E 4474/4885
US-20100144046-A1 CYCLOMETALATED TRANSITION METAL COMPLEXES FOR MULTIPLEX ANALYTE DETECTION CAD, NCLN, CCL5 ALDH1A1 2447/4885RAB9A 4443/4885KDM4E 4831/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.